Literature DB >> 27871412

Role of Recombinant Human Bone Morphogenetic Protein-2 on Hindfoot Arthrodesis.

Jeremy Hreha1, Ethan S Krell1, Christopher Bibbo2.   

Abstract

Despite advances in understanding bone healing physiology and surgical techniques, delayed union and nonunion still occur after the treatment of hindfoot arthrodesis. There is increasing appeal of bone morphogenetic proteins (BMPs) owing to the innate osteoinductive abilities of BMPs. Effective treatment with BMPs has been shown in animal studies. Human clinical studies have also shown success. The only study investigating the use of recombinant human BMP (rhBMP)-2 in hindfoot arthrodesis found a significant increase in fusion rate. Treatment cost effective. Complications from their use remain low. rhBMP-2 is a safe and effective bone-healing adjunct in hindfoot arthrodesis surgery.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arthrodesis; Fusion; Hindfoot; Orthobiologics; rhBMP-2

Mesh:

Substances:

Year:  2016        PMID: 27871412     DOI: 10.1016/j.fcl.2016.07.001

Source DB:  PubMed          Journal:  Foot Ankle Clin        ISSN: 1083-7515            Impact factor:   1.653


  3 in total

1.  A meta-analysis of bone morphogenetic protein-2 versus iliac crest bone graft for the posterolateral fusion of the lumbar spine.

Authors:  Gonzalo Mariscal; Jorge H Nuñez; Carlos Barrios; Pedro Domenech-Fernández
Journal:  J Bone Miner Metab       Date:  2019-07-10       Impact factor: 2.626

Review 2.  The role of biologic in foot and ankle trauma-a review of the literature.

Authors:  Emily Zhao; Dwayne Carney; Monique Chambers; Samuel Ewalefo; MaCalus Hogan
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

3.  Relationship between BMP2/9 Levels and Spinal Function and Quality of Life in Patients with Severe Scoliosis after PVCR.

Authors:  Quan Li; Zhi Zhao; Jingming Xie; Ying Zhang; Tao Li; Yingsong Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-29       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.